Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,226 | 221 | 4,459 | 51,579 | 7,314 |
| Cost of Goods | 216 | N/A | N/A | N/A | N/A |
| Gross Profit | 1,010 | 221 | 4,459 | 51,579 | 7,314 |
| Operating Expenses | 76,244 | 75,760 | 89,081 | 83,711 | 95,534 |
| Operating Income | -75,018 | -75,539 | -84,622 | -32,132 | -88,220 |
| Interest Expense | 1,336 | 117 | 123 | 129 | 4 |
| Other Income | 1,605 | 1,086 | 664 | 50,727 | 119 |
| Pre-tax Income | -74,749 | -74,570 | -84,081 | 18,466 | -88,105 |
| Income Tax | 22 | 2 | 10 | N/A | N/A |
| Net Income Continuous | -74,771 | -74,572 | -84,091 | 18,466 | -88,105 |
| Net Income | $-74,771 | $-74,572 | $-84,091 | $18,466 | $-88,105 |
| EPS Basic Total Ops | -18.00 | -18.25 | -20.50 | 4.50 | -21.75 |
| EPS Basic Continuous Ops | -17.98 | -18.11 | -20.53 | 4.54 | -21.87 |
| EPS Diluted Total Ops | -18.00 | -18.25 | -20.50 | 4.50 | -21.75 |
| EPS Diluted Continuous Ops | -17.98 | -18.10 | -20.53 | 4.53 | -21.87 |
| EPS Diluted Before Non-Recurring Items | -18.00 | -18.00 | -20.50 | N/A | N/A |
| EBITDA(a) | $-74,155 | $-74,234 | $-83,090 | $-30,381 | $-86,131 |